Monday - February 02, 2026

Ibogaine BY David Dardashti Unveils “Sovereign Guardian” Protocol: A Radical New Framework for Ibogaine Integration and Trauma Recovery

PLAYA DEL CARMEN, MEXICO – January 26, 2026 – David Dardashti, a leading pioneer in Ibogaine therapy and trauma recovery, has officially announced the launch of the Sovereign Guardian Questionnaire. This specialized psychological framework is designed to bridge the gap between … Continue reading

Data Index, an independent job platform for UK data science roles, finds data science hiring concentrating around defined use cases as organisations tighten experimentation into delivery

Data Index reviews UK data science job ad language and explains the move toward defined use cases, measurable impact, and production delivery. UK data jobs platform, Data Index, reviews how data science roles are being described and why listings increasingly … Continue reading

Quantum AI Launches New International French Platform to Serve Global Francophone Community

Quantum AI announces the launch of its new international French-language platform quantumaifr.com to serve French-speaking users worldwide. Quantum AI announces the launch of its new international French-language website, quantumaifr.com, expanding access to advanced artificial intelligence resources for French-speaking users worldwide … Continue reading

Best Skincare for Men: Strive Recognized as a Leading Men’s Brand for Ingredient Transparency and Science-Backed Formulas

Strive logo — the chemist-founded men’s skincare brand recognized among the Best Skincare Brands for Men of 2026 for ingredient transparency and science-backed formulations. Strive, a chemist-founded men’s skincare brand, has been recognized among the Best Skincare Brands for Men … Continue reading

Persistent Corneal Epithelial Defects Treatment Pipeline Shows Strong Momentum as 5+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Persistent Corneal Epithelial Defects Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Persistent Corneal Epithelial Defects pipeline landscape. It covers the Persistent Corneal Epithelial Defects pipeline drug profiles, including clinical and nonclinical … Continue reading

Autistic Disorder Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Autistic Disorder Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Autistic Disorder pipeline landscape. It covers the Autistic Disorder pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading